Skyscape Web Viewer : CURRENT Practice Guidelines In Primary Care : Table Index

View All
Table 2-6 Risk Factors For VTE in Hospitalized Medical Patients
Table 19-4 Rate Control in Atrial Fibrillation: Antiarrhythmics
Table 19-6 Has-Bled Bleeding Risk Score For Warfarin Therapy
Table 19-8 Comparing Warfarin with Doacs
Table 1 Recommended Child and Adolescent Immunization Schedule For Ages 18 Y or Younger, United States, 2023
Table 2-10 Caprini Risk Stratification Model
Table 21-2 Recommendations For Adjunctive Diabetes Therapies Complementary to Common Comorbidities
Table 2-1 ASCVD Groups That Benefit From Statin Therapy
Table 22-2 Types of Sinusitis and Their Management
Table 23-1 Acute Diarrhea Antibiotic Treatment Recommendations
Table 24-1 Responses to Abnormal Screening Results, Patients Age 25-65 Without Prior Anomaliesa
Table 24-3 Management of Return Cytology and HPV After Cin 2 Colposcopya
Table 24-5 American College of Radiology (Acr) Appropriateness Criteria For Hematuria
Table 25-10 First-Line Therapy For ITP
Table 25-1 Common Causes of Anemia
Table 25-3 Infectious Complications of Transfusion
Table 25-5 Wells Score For Pe
Table 25-7 Recommended Anticoagulant Selection and Duration of Anticoagulation For Pulmonary Embolism Based On Risk Factors and Location of Pulmonary Embolism
Table 25-9 Diagnostic Tool For Diagnosis of HIT
Table 26-2 Medical Conditions That Increase Risk of Progression to Severe COVID
Table 26-4 Sexually Transmitted Diseases Treatment Guidelines
Table 2-7 Risk Factors For Bleeding (Chest. 2011;139:69-79)
Table 28-4 Example of Serious Medical Conditions That Might Warrant Consideration of Further Evalution and Therapy in Hospital Setting
Table 29-1 Cdc Medical Eligibility Criteria for Contraceptive Use
Table 29-3 Extended Use of Long-Acting Reversible Contraception
Table 29-6 Aap and Afp Perinatal and Postnatal Guidelines
Table 28-2 National Institutes of Health Stroke Scale Score
Table 2-8 Improve Bleeding Risk Scale
Table 29-2 Percentage of Women Experiencing an Unintended Pregnancy Within the First Year of Typical Use and the First Year of Perfect Use and the Percentage Continuing Use At the End of the First Year: United States
Table 29-4 Timing of Delivery in Pregnant Patients with Chronic Hypertension